Combination of HMG-CoA reductase inhibitors amd mTOR inhibitors

Details for Australian Patent Application No. 2006254397 (hide)

Owner Novartis AG

Inventors Dorent, Richard Jean; Sips, Carole Anne

Agent Davies Collison Cave

Pub. Number AU-A-2006254397

PCT Pub. Number WO2006/128660

Priority 60/685,849 31.05.05 US

Filing date 29 May 2006

Wipo publication date 7 December 2006

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/404 (2006.01)

A61K 31/436 (2006.01)

A61K 31/47 (2006.01) - Quinolines

Event Publications

20 December 2007 PCT application entered the National Phase

  PCT publication WO2006/128660 Priority application(s): WO2006/128660

7 February 2008 Amendment Made

  The nature of the amendment is: Amend the invention title to read Combination of HMG-CoA reductase inhibitors and mTOR inhibitors

3 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006254402-Absorbent single-use article

2006254396-Organic compounds